Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Unknown 5Completed 2Active not recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Carcinoma, Non-Small-Cell Lung 73Lung Neoplasms 32Breast Neoplasms 19Head and Neck Neoplasms 16Neoplasms 11Glioblastoma 8Adenocarcinoma of Lung 8Squamous Cell Carcinoma of Head and Neck 7Colorectal Neoplasms 7Brain Neoplasms 7Adenocarcinoma, Bronchiolo-Alveolar 7Prostatic Neoplasms 6Neoplasm Metastasis 6Gliosarcoma 6Rectal Neoplasms 5Ovarian Neoplasms 5Colonic Neoplasms 5Esophageal Neoplasms 4Central Nervous System Neoplasms 4Carcinoma 4Unspecified Adult Solid Tumor, Protocol Specific 3Respiratory Tract Diseases 3Fallopian Tube Neoplasms 3Carcinoma, Renal Cell 3Carcinoma, Ovarian Epithelial 3Adenocarcinoma Of Esophagus 3Adenocarcinoma 3Urinary Bladder Neoplasms 2Thyroid Neoplasms 2Thyroid Carcinoma, Anaplastic 2

Interventions

osimertinib 2Vinorelbine 2Pemetrexed 2Liquid Biopsy 2HMPL-013 2Gefitinib 2Carboplatin 2tislelizumab 1sulindac sulfone 1rezivertinib 1pembrolizumab 1anlotinib 1Radiotherapy 1Platinum 1Paclitaxel 1Gemcitabine 1Cisplatin 1Cetuximab 1CP protocol 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × NSCLC × Gefitinib × Clear all
NCT02976116 2019-11-15

A Phase II Study of Fruquintinib in Combination With Gefitinib in Patients With Advanced Non-small Cell Lung Cancer

Hutchmed

Phase 2 Completed
50 enrolled
Thoracic

NSCLC

NCT00259064 2016-06-02

INSTEP

AstraZeneca

Phase 2/3 Completed
216 enrolled
Thoracic

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon âš¡